nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—OPRM1—nicotine dependence	0.813	1	CbGaD
Hydromorphone—Abnormal faeces—Varenicline—nicotine dependence	0.00591	0.0393	CcSEcCtD
Hydromorphone—Haematochezia—Varenicline—nicotine dependence	0.0042	0.0279	CcSEcCtD
Hydromorphone—Withdrawal symptom—Varenicline—nicotine dependence	0.00412	0.0274	CcSEcCtD
Hydromorphone—Dysphoria—Varenicline—nicotine dependence	0.00391	0.026	CcSEcCtD
Hydromorphone—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00345	0.0229	CcSEcCtD
Hydromorphone—Suicide—Varenicline—nicotine dependence	0.00326	0.0217	CcSEcCtD
Hydromorphone—Balance disorder—Varenicline—nicotine dependence	0.00309	0.0206	CcSEcCtD
Hydromorphone—Sexual dysfunction—Varenicline—nicotine dependence	0.00301	0.02	CcSEcCtD
Hydromorphone—Completed suicide—Varenicline—nicotine dependence	0.00287	0.0191	CcSEcCtD
Hydromorphone—Paranoia—Varenicline—nicotine dependence	0.00248	0.0165	CcSEcCtD
Hydromorphone—Menstrual disorder—Varenicline—nicotine dependence	0.00248	0.0165	CcSEcCtD
Hydromorphone—Intestinal obstruction—Varenicline—nicotine dependence	0.00248	0.0165	CcSEcCtD
Hydromorphone—Nystagmus—Varenicline—nicotine dependence	0.00237	0.0157	CcSEcCtD
Hydromorphone—Rhinorrhoea—Varenicline—nicotine dependence	0.00209	0.0139	CcSEcCtD
Hydromorphone—Endocrine disorder—Varenicline—nicotine dependence	0.00204	0.0136	CcSEcCtD
Hydromorphone—Disturbance in attention—Varenicline—nicotine dependence	0.00195	0.013	CcSEcCtD
Hydromorphone—Aggression—Varenicline—nicotine dependence	0.00192	0.0128	CcSEcCtD
Hydromorphone—Chest discomfort—Varenicline—nicotine dependence	0.00191	0.0127	CcSEcCtD
Hydromorphone—Accidental injury—Varenicline—nicotine dependence	0.00191	0.0127	CcSEcCtD
Hydromorphone—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00187	0.0124	CcSEcCtD
Hydromorphone—Dysarthria—Varenicline—nicotine dependence	0.00179	0.0119	CcSEcCtD
Hydromorphone—Coordination abnormal—Varenicline—nicotine dependence	0.00172	0.0114	CcSEcCtD
Hydromorphone—Abnormal dreams—Varenicline—nicotine dependence	0.00167	0.0111	CcSEcCtD
Hydromorphone—Eructation—Varenicline—nicotine dependence	0.00166	0.011	CcSEcCtD
Hydromorphone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00162	0.0615	CbGpPWpGaD
Hydromorphone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0016	0.0609	CbGpPWpGaD
Hydromorphone—Dry eye—Varenicline—nicotine dependence	0.00156	0.0104	CcSEcCtD
Hydromorphone—Urine output increased—Varenicline—nicotine dependence	0.00153	0.0102	CcSEcCtD
Hydromorphone—Euphoric mood—Varenicline—nicotine dependence	0.00145	0.00965	CcSEcCtD
Hydromorphone—Polyuria—Varenicline—nicotine dependence	0.0014	0.00929	CcSEcCtD
Hydromorphone—Disorientation—Varenicline—nicotine dependence	0.00137	0.00912	CcSEcCtD
Hydromorphone—Injury—Varenicline—nicotine dependence	0.00133	0.00887	CcSEcCtD
Hydromorphone—Libido decreased—Varenicline—nicotine dependence	0.00132	0.00879	CcSEcCtD
Hydromorphone—Increased appetite—Varenicline—nicotine dependence	0.00131	0.00868	CcSEcCtD
Hydromorphone—Amnesia—Varenicline—nicotine dependence	0.00131	0.00868	CcSEcCtD
Hydromorphone—Visual disturbance—Varenicline—nicotine dependence	0.00129	0.00861	CcSEcCtD
Hydromorphone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00126	0.048	CbGpPWpGaD
Hydromorphone—Lethargy—Varenicline—nicotine dependence	0.00125	0.00832	CcSEcCtD
Hydromorphone—Osteoarthritis—Varenicline—nicotine dependence	0.00123	0.00816	CcSEcCtD
Hydromorphone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00122	0.00809	CcSEcCtD
Hydromorphone—Affect lability—Varenicline—nicotine dependence	0.00121	0.00803	CcSEcCtD
Hydromorphone—Migraine—Varenicline—nicotine dependence	0.00121	0.00803	CcSEcCtD
Hydromorphone—Psychotic disorder—Varenicline—nicotine dependence	0.0012	0.00797	CcSEcCtD
Hydromorphone—Urinary retention—Varenicline—nicotine dependence	0.00117	0.00776	CcSEcCtD
Hydromorphone—Mood swings—Varenicline—nicotine dependence	0.00116	0.00773	CcSEcCtD
Hydromorphone—Abdominal pain upper—Varenicline—nicotine dependence	0.00112	0.00745	CcSEcCtD
Hydromorphone—Breast disorder—Varenicline—nicotine dependence	0.00111	0.00737	CcSEcCtD
Hydromorphone—Cramp muscle—Varenicline—nicotine dependence	0.0011	0.00734	CcSEcCtD
Hydromorphone—Nasopharyngitis—Varenicline—nicotine dependence	0.0011	0.00729	CcSEcCtD
Hydromorphone—Gastritis—Varenicline—nicotine dependence	0.00109	0.00722	CcSEcCtD
Hydromorphone—Abdominal distension—Varenicline—nicotine dependence	0.00107	0.0071	CcSEcCtD
Hydromorphone—Asthma—Varenicline—nicotine dependence	0.00106	0.00705	CcSEcCtD
Hydromorphone—Dysphagia—Varenicline—nicotine dependence	0.00106	0.00705	CcSEcCtD
Hydromorphone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.001	0.0381	CbGpPWpGaD
Hydromorphone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.000994	0.0378	CbGpPWpGaD
Hydromorphone—Pollakiuria—Varenicline—nicotine dependence	0.000979	0.00651	CcSEcCtD
Hydromorphone—Erectile dysfunction—Varenicline—nicotine dependence	0.000976	0.00649	CcSEcCtD
Hydromorphone—Infestation NOS—Varenicline—nicotine dependence	0.000945	0.00629	CcSEcCtD
Hydromorphone—Infestation—Varenicline—nicotine dependence	0.000945	0.00629	CcSEcCtD
Hydromorphone—Depression—Varenicline—nicotine dependence	0.000942	0.00627	CcSEcCtD
Hydromorphone—Stomatitis—Varenicline—nicotine dependence	0.000921	0.00613	CcSEcCtD
Hydromorphone—Heroin—OPRM1—nicotine dependence	0.000905	0.0854	CrCbGaD
Hydromorphone—Hepatobiliary disease—Varenicline—nicotine dependence	0.000894	0.00594	CcSEcCtD
Hydromorphone—Bradycardia—Varenicline—nicotine dependence	0.000864	0.00574	CcSEcCtD
Hydromorphone—Hallucination—Varenicline—nicotine dependence	0.000844	0.00561	CcSEcCtD
Hydromorphone—Hypoaesthesia—Varenicline—nicotine dependence	0.000844	0.00561	CcSEcCtD
Hydromorphone—Urinary tract disorder—Varenicline—nicotine dependence	0.000838	0.00557	CcSEcCtD
Hydromorphone—Oedema peripheral—Varenicline—nicotine dependence	0.000836	0.00556	CcSEcCtD
Hydromorphone—Connective tissue disorder—Varenicline—nicotine dependence	0.000834	0.00554	CcSEcCtD
Hydromorphone—Urethral disorder—Varenicline—nicotine dependence	0.000832	0.00553	CcSEcCtD
Hydromorphone—Visual impairment—Varenicline—nicotine dependence	0.000818	0.00544	CcSEcCtD
Hydromorphone—Methylnaltrexone—OPRM1—nicotine dependence	0.000807	0.0761	CrCbGaD
Hydromorphone—Eye disorder—Varenicline—nicotine dependence	0.000793	0.00527	CcSEcCtD
Hydromorphone—Tinnitus—Varenicline—nicotine dependence	0.000791	0.00526	CcSEcCtD
Hydromorphone—Dextromethorphan—CHRNB4—nicotine dependence	0.000789	0.0744	CrCbGaD
Hydromorphone—Cardiac disorder—Varenicline—nicotine dependence	0.000787	0.00524	CcSEcCtD
Hydromorphone—Angiopathy—Varenicline—nicotine dependence	0.00077	0.00512	CcSEcCtD
Hydromorphone—Immune system disorder—Varenicline—nicotine dependence	0.000766	0.0051	CcSEcCtD
Hydromorphone—Mediastinal disorder—Varenicline—nicotine dependence	0.000765	0.00508	CcSEcCtD
Hydromorphone—Chills—Varenicline—nicotine dependence	0.000761	0.00506	CcSEcCtD
Hydromorphone—Arrhythmia—Varenicline—nicotine dependence	0.000758	0.00504	CcSEcCtD
Hydromorphone—Mental disorder—Varenicline—nicotine dependence	0.000743	0.00494	CcSEcCtD
Hydromorphone—Erythema—Varenicline—nicotine dependence	0.000739	0.00491	CcSEcCtD
Hydromorphone—Malnutrition—Varenicline—nicotine dependence	0.000739	0.00491	CcSEcCtD
Hydromorphone—Nalbuphine—OPRM1—nicotine dependence	0.000738	0.0696	CrCbGaD
Hydromorphone—Flatulence—Varenicline—nicotine dependence	0.000728	0.00484	CcSEcCtD
Hydromorphone—Dysgeusia—Varenicline—nicotine dependence	0.000723	0.00481	CcSEcCtD
Hydromorphone—Dextromethorphan—CHRNB2—nicotine dependence	0.000722	0.0681	CrCbGaD
Hydromorphone—Back pain—Varenicline—nicotine dependence	0.000714	0.00475	CcSEcCtD
Hydromorphone—Levorphanol—OPRM1—nicotine dependence	0.00071	0.067	CrCbGaD
Hydromorphone—Muscle spasms—Varenicline—nicotine dependence	0.00071	0.00472	CcSEcCtD
Hydromorphone—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000703	0.0267	CbGpPWpGaD
Hydromorphone—Vision blurred—Varenicline—nicotine dependence	0.000696	0.00463	CcSEcCtD
Hydromorphone—Tremor—Varenicline—nicotine dependence	0.000692	0.0046	CcSEcCtD
Hydromorphone—Dihydrocodeine—OPRM1—nicotine dependence	0.000686	0.0647	CrCbGaD
Hydromorphone—Ill-defined disorder—Varenicline—nicotine dependence	0.000685	0.00456	CcSEcCtD
Hydromorphone—Agitation—Varenicline—nicotine dependence	0.000679	0.00451	CcSEcCtD
Hydromorphone—Angioedema—Varenicline—nicotine dependence	0.000675	0.00449	CcSEcCtD
Hydromorphone—Malaise—Varenicline—nicotine dependence	0.000666	0.00443	CcSEcCtD
Hydromorphone—Vertigo—Varenicline—nicotine dependence	0.000664	0.00441	CcSEcCtD
Hydromorphone—Syncope—Varenicline—nicotine dependence	0.000662	0.0044	CcSEcCtD
Hydromorphone—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000662	0.0251	CbGpPWpGaD
Hydromorphone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000655	0.0249	CbGpPWpGaD
Hydromorphone—Palpitations—Varenicline—nicotine dependence	0.000653	0.00434	CcSEcCtD
Hydromorphone—Loss of consciousness—Varenicline—nicotine dependence	0.000649	0.00432	CcSEcCtD
Hydromorphone—Cough—Varenicline—nicotine dependence	0.000645	0.00429	CcSEcCtD
Hydromorphone—Convulsion—Varenicline—nicotine dependence	0.00064	0.00426	CcSEcCtD
Hydromorphone—Hypertension—Varenicline—nicotine dependence	0.000638	0.00424	CcSEcCtD
Hydromorphone—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000636	0.0242	CbGpPWpGaD
Hydromorphone—Myalgia—Varenicline—nicotine dependence	0.000629	0.00418	CcSEcCtD
Hydromorphone—Arthralgia—Varenicline—nicotine dependence	0.000629	0.00418	CcSEcCtD
Hydromorphone—Chest pain—Varenicline—nicotine dependence	0.000629	0.00418	CcSEcCtD
Hydromorphone—Anxiety—Varenicline—nicotine dependence	0.000627	0.00417	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000625	0.00415	CcSEcCtD
Hydromorphone—Discomfort—Varenicline—nicotine dependence	0.000621	0.00413	CcSEcCtD
Hydromorphone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000616	0.0234	CbGpPWpGaD
Hydromorphone—Dry mouth—Varenicline—nicotine dependence	0.000615	0.00409	CcSEcCtD
Hydromorphone—Naltrexone—OPRM1—nicotine dependence	0.000601	0.0567	CrCbGaD
Hydromorphone—Oxymorphone—OPRM1—nicotine dependence	0.000601	0.0567	CrCbGaD
Hydromorphone—Infection—Varenicline—nicotine dependence	0.000599	0.00398	CcSEcCtD
Hydromorphone—Shock—Varenicline—nicotine dependence	0.000593	0.00394	CcSEcCtD
Hydromorphone—Nervous system disorder—Varenicline—nicotine dependence	0.000591	0.00393	CcSEcCtD
Hydromorphone—Tachycardia—Varenicline—nicotine dependence	0.000588	0.00391	CcSEcCtD
Hydromorphone—Skin disorder—Varenicline—nicotine dependence	0.000586	0.00389	CcSEcCtD
Hydromorphone—Hyperhidrosis—Varenicline—nicotine dependence	0.000583	0.00388	CcSEcCtD
Hydromorphone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00058	0.022	CbGpPWpGaD
Hydromorphone—Ethylmorphine—OPRM1—nicotine dependence	0.000575	0.0542	CrCbGaD
Hydromorphone—Anorexia—Varenicline—nicotine dependence	0.000575	0.00382	CcSEcCtD
Hydromorphone—Hypotension—Varenicline—nicotine dependence	0.000563	0.00375	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000549	0.00365	CcSEcCtD
Hydromorphone—Dextromethorphan—CHRNA3—nicotine dependence	0.000547	0.0516	CrCbGaD
Hydromorphone—Insomnia—Varenicline—nicotine dependence	0.000545	0.00363	CcSEcCtD
Hydromorphone—Dyspnoea—Varenicline—nicotine dependence	0.000537	0.00357	CcSEcCtD
Hydromorphone—Somnolence—Varenicline—nicotine dependence	0.000536	0.00356	CcSEcCtD
Hydromorphone—Dyspepsia—Varenicline—nicotine dependence	0.000531	0.00353	CcSEcCtD
Hydromorphone—Hydrocodone—OPRM1—nicotine dependence	0.000526	0.0496	CrCbGaD
Hydromorphone—Decreased appetite—Varenicline—nicotine dependence	0.000524	0.00348	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00052	0.00346	CcSEcCtD
Hydromorphone—Fatigue—Varenicline—nicotine dependence	0.00052	0.00346	CcSEcCtD
Hydromorphone—Pain—Varenicline—nicotine dependence	0.000516	0.00343	CcSEcCtD
Hydromorphone—Constipation—Varenicline—nicotine dependence	0.000516	0.00343	CcSEcCtD
Hydromorphone—Feeling abnormal—Varenicline—nicotine dependence	0.000497	0.0033	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Varenicline—nicotine dependence	0.000493	0.00328	CcSEcCtD
Hydromorphone—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00049	0.0186	CbGpPWpGaD
Hydromorphone—Oxycodone—OPRM1—nicotine dependence	0.00048	0.0452	CrCbGaD
Hydromorphone—Urticaria—Varenicline—nicotine dependence	0.000479	0.00318	CcSEcCtD
Hydromorphone—Abdominal pain—Varenicline—nicotine dependence	0.000477	0.00317	CcSEcCtD
Hydromorphone—Body temperature increased—Varenicline—nicotine dependence	0.000477	0.00317	CcSEcCtD
Hydromorphone—Codeine—OPRM1—nicotine dependence	0.000458	0.0432	CrCbGaD
Hydromorphone—Hypersensitivity—Varenicline—nicotine dependence	0.000444	0.00295	CcSEcCtD
Hydromorphone—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00044	0.0167	CbGpPWpGaD
Hydromorphone—Naloxone—OPRM1—nicotine dependence	0.000439	0.0414	CrCbGaD
Hydromorphone—Asthenia—Varenicline—nicotine dependence	0.000433	0.00288	CcSEcCtD
Hydromorphone—Pruritus—Varenicline—nicotine dependence	0.000427	0.00284	CcSEcCtD
Hydromorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000416	0.0158	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.000415	0.0158	CbGpPWpGaD
Hydromorphone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000413	0.0157	CbGpPWpGaD
Hydromorphone—Diarrhoea—Varenicline—nicotine dependence	0.000412	0.00274	CcSEcCtD
Hydromorphone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000411	0.0156	CbGpPWpGaD
Hydromorphone—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000409	0.0155	CbGpPWpGaD
Hydromorphone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000407	0.0155	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000401	0.0152	CbGpPWpGaD
Hydromorphone—Dizziness—Varenicline—nicotine dependence	0.000399	0.00265	CcSEcCtD
Hydromorphone—Vomiting—Varenicline—nicotine dependence	0.000383	0.00255	CcSEcCtD
Hydromorphone—Rash—Varenicline—nicotine dependence	0.00038	0.00253	CcSEcCtD
Hydromorphone—Dermatitis—Varenicline—nicotine dependence	0.00038	0.00253	CcSEcCtD
Hydromorphone—Headache—Varenicline—nicotine dependence	0.000378	0.00251	CcSEcCtD
Hydromorphone—Morphine—OPRM1—nicotine dependence	0.00037	0.0349	CrCbGaD
Hydromorphone—Nausea—Varenicline—nicotine dependence	0.000358	0.00238	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000351	0.0133	CbGpPWpGaD
Hydromorphone—Dextromethorphan—CHRNA4—nicotine dependence	0.000338	0.0319	CrCbGaD
Hydromorphone—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.000338	0.0128	CbGpPWpGaD
Hydromorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000337	0.0128	CbGpPWpGaD
Hydromorphone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000335	0.0127	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000331	0.0126	CbGpPWpGaD
Hydromorphone—Dextromethorphan—OPRM1—nicotine dependence	0.000311	0.0293	CrCbGaD
Hydromorphone—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000297	0.0113	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00029	0.011	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000279	0.0106	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000272	0.0103	CbGpPWpGaD
Hydromorphone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000269	0.0102	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000259	0.00984	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000245	0.00929	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000227	0.00862	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000226	0.0086	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000222	0.00843	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000221	0.00838	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000206	0.00781	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000202	0.00766	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000198	0.00754	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000194	0.00739	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00019	0.00723	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000189	0.00716	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000187	0.00711	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00018	0.00685	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000179	0.00681	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000178	0.00675	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000178	0.00675	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000177	0.00672	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000177	0.00672	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000175	0.00666	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000169	0.00642	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000168	0.00637	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000164	0.00624	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000161	0.00613	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00016	0.00609	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000156	0.00592	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000152	0.00579	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000149	0.00568	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000148	0.00563	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000141	0.00537	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000141	0.00534	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000139	0.00527	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000132	0.005	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000124	0.00473	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000122	0.00464	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000121	0.00461	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00012	0.00454	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000119	0.00451	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000117	0.00445	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000116	0.00439	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.00407	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.00405	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	9.54e-05	0.00363	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGD1—nicotine dependence	9.53e-05	0.00362	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	9.05e-05	0.00344	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	9e-05	0.00342	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	8.67e-05	0.00329	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	8.42e-05	0.0032	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	8.37e-05	0.00318	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	8.36e-05	0.00318	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	7.6e-05	0.00289	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	7.38e-05	0.0028	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP2A7—nicotine dependence	7.09e-05	0.0027	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGD1—nicotine dependence	7.06e-05	0.00268	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	6.9e-05	0.00262	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	6.26e-05	0.00238	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	6.24e-05	0.00237	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	6.05e-05	0.0023	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—WASF2—nicotine dependence	5.93e-05	0.00225	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP2A7—nicotine dependence	5.78e-05	0.0022	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—WASF1—nicotine dependence	5.69e-05	0.00216	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	5.49e-05	0.00209	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	5.2e-05	0.00198	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	5.12e-05	0.00195	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	5.11e-05	0.00194	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	4.99e-05	0.00189	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	4.64e-05	0.00176	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	4.49e-05	0.00171	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—WASF2—nicotine dependence	4.39e-05	0.00167	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—WASF1—nicotine dependence	4.21e-05	0.0016	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—DRD2—nicotine dependence	3.7e-05	0.00141	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.25e-05	0.00123	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.07e-05	0.00117	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	3.04e-05	0.00115	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.74e-05	0.00104	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2e-05	0.000762	CbGpPWpGaD
